Micafungina Accord

Micafungin, the active ingredient in Micafungina Accord, is an echinocandin antifungal presented as an intravenous solution for intravenous use. It treats invasive candidiasis, esophageal candidiasis, candidemia and is used for prophylaxis of fungal infections in hematopoietic stem cell transplantation.

GNH USA supplies Micafungina Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product complies with EU quality standards and is available for bulk and unit‑dose distribution. GNH USA ensures temperature‑controlled logistics and regulatory documentation for seamless import.

Micafungin is an echinocandin antifungal used to treat serious Candida infections.

- Invasive candidiasis: effective in clearing bloodstream and deep‑tissue Candida infections. - Esophageal candidiasis: resolves mucosal infection and associated pain. - Candidemia: eliminates Candida species from the bloodstream. - Prophylaxis in hematopoietic stem cell transplantation: prevents invasive fungal infections in high‑risk patients.

Micafungin may cause adverse reactions ranging from mild to serious.

Common Side Effects: - Fever: transient elevation of body temperature. - Nausea: mild to moderate stomach upset. - Headache: occasional mild headache. - Elevated liver enzymes: mild increase in ALT/AST. - Rash: mild skin redness or itching.

Serious or Rare Side Effects: - Hypersensitivity reactions: including anaphylaxis. - Hepatotoxicity: significant liver injury. - Severe infusion-related reactions: hypotension or bronchospasm. - Nephrotoxicity: rare kidney function impairment.

Before using Micafungina Accord, consider the following precautions to ensure safe administration.

- Renal impairment: assess kidney function and adjust monitoring. - Hepatic dysfunction: monitor liver enzymes regularly. - Concomitant hepatotoxic drugs: avoid or use with caution. - Pregnancy and lactation: use only if benefits outweigh risks. - Drug interactions: review concomitant medications for potential interactions. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Micafungin can interact with other medicines; the following interactions are recognized.

Major Interactions (Avoid): - Cyclosporine: increased micafungin exposure may raise toxicity risk. - Rifampin: strong enzyme induction may reduce micafungin levels.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of anticoagulant effect. - Azole antifungals (e.g., fluconazole): may increase micafungin concentrations. - Statins (e.g., simvastatin): monitor for increased risk of myopathy. - Immunosuppressants (e.g., tacrolimus): adjust dosing based on levels.